UHUD Trial
AHA 2021
Presented at the 2021 American Heart Association Conference.
Trial design
Single arm, prospective trial
50 consecutive patients undergoing diagnostic invasive catheterization at the University of Minnesota.
Either diagnostic coronary angiography or right heart catheterization.
Inclusion criteria
>18 years of age
Exclusion criteria
Planned interventional procedure
Endomyocardial biopsy
Emergent procedure
Consent obtained for both patient and physician.
Methods
Vascular access either right or left internal jugular for right heart catheterization or right or left radial / ulnar for coronary angiography.
AR headset used as a primary monitor for guiding the procedure with standard display immediately available in case of headset failure.
No Complications
It is the only mixed reality system that has been shown to be safe and feasible in a clinical trial. None of the fifty patients had any peri-procedure or post-procedure complications.